Agian
Well-known member
Coronary heart disease (CHD) event rates in secondary prevention
trials (5 years in duration except the PROVE-IT study, which was 2
years) were directly proportional to low-density lipoprotein (LDL) cholesterol
levels. The event rate is predicted to approach 0 at LDL of 30 mg/dl
(8–12).
trials (5 years in duration except the PROVE-IT study, which was 2
years) were directly proportional to low-density lipoprotein (LDL) cholesterol
levels. The event rate is predicted to approach 0 at LDL of 30 mg/dl
(8–12).